Q: Hi Peter, can you comment on the latest news release today on Well Health's Wellstar company and what are the forecast earnings for this Thursday's financial reporting.
thank you
thank you
5i Research Answer:
WELL EPS of 20c beat estimates of 9c; revenue of $384.8M matched estimates. EBITDA of $66.5M was 5% better. Guidance for the year is $1.55B and EBITDA $175M+. Sales guidance is in line with estimates, EBITDA is a bit lower. WELL notes its acquisition pipeline remains active. We would consider it quarter decent. The revenue ramp is solid and it is becoming more profitable. Wellstar has completed two more billing acquisitions. This is positive, but the impact is not huge-only $5M in revenue will be added, bringing run rate to $84M. Still good news, however.